Friday, May 1, 2026

How Seers’ mobiCARE and thynC are Transforming Heart Disease Management in Asia

Seers Technology is revolutionizing digital healthcare with AI and wearable tech, achieving strong growth and targeting international markets.

Trump-Era National Defense Strategy: Why Washington Is Recasting South Korea’s Role on the Peninsula

The U.S.-South Korea alliance shifts as South Korea takes on more defense responsibility, with the U.S. reducing its military role.

Will Park Chan-wook’s No Other Choice Make Oscar History? Insights on Its Box Office Success

Park Chan-wook's film "No Other Choice" is a box office success but may miss an Oscar nomination despite its popularity in the U.S.

Tag: R&D

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Cha Biotech Announces Support of K-Bio Startups at Bio Korea 2026

Cha Biotech aims to create a global innovation ecosystem for K-Bio startups through the K-Bio CIC Open Innovation Center.

How the 2026 Drug Price Reform Will Reshape the Pharmaceutical Industry

Experts discuss the impact of drug pricing reform on the pharmaceutical sector, urging innovation and strategic shifts in R&D investments.

Samjin Pharm Selected as Leading Biotech Firm in Government-Backed ‘World Class Plus’ Project

Samjin Pharm selected for the "World Class Plus Project" to enhance global competitiveness in biotech with innovative drug developments.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

SK Nexilis to Showcase 4-Micrometer Ultra-Wide Copper Foil at InterBattery 2026

SK Nexilis will showcase innovative copper foil technology at InterBattery 2026, enhancing productivity for battery manufacturers.

Future of EV Batteries—Dongwha Electrolyte’s R&D Roadmap Revealed

Dongwha Electrolyte will present its R&D roadmap and strategies for global battery regulations at InterBattery 2026 in Seoul.

Can Samjin Pharm Overcome Generic Drug Price Cuts With AI-Driven Drug Development?

Samjin Pharm shifts focus to R&D, moving away from generics to innovative drug development, amid government price cuts.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

Chinese & Indian Medical Invasion: Pharmaceutic Dependency on Risk of Essential Medicine Supply

Concerns rise over South Korea's API industry reliance on China and India, with self-sufficiency at a record low of 25.6% in 2023.

South Korea’s Auto Industry Is Being Hollowed Out—And No One’s Sounding the Alarm

South Korea's auto industry faces challenges from global competition, requiring R&D enhancements and local production incentives for future mobility.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.